106 Kaunitz AM, Arias R, McClung M. Bone density recovery after depot medrozyprogesterone acetate injectable contraception use. Contraception 2008;77:67–76. 107 Hartard M, Kleinmond C, Wiseman M, et al. Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone 2007;40:444–50. 108 Vescovi JD, Jamal SA, De Souza MJ. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature. Osteoporos Int 2008;19:465–78. 109 Misra M, Prabhakaran R, Miller KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008;93:1231–7. 110 Compston JE, McConachie C, Stott C, et al. Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int 2006;17:77–84. 111 Ackerman KE, Misra M. Bone health and the female athlete triad in adolescent athletes. Phys Sports Med 2011;39:131–41. 112 Viapiana O, Gatti D, Dalle GR, et al. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone 2007;40:1073–7. 113 Nichols JF, Rauh MJ, Barrack MT, et al. Bone mineral density in female high school athletes: interactions of menstrual function and type of mechanical loading. Bone 2007;41:371–7. 114 Vicente-Rodriguez G. How does exercise affect bone development during growth? Sports Med 2006;36:561–9. 115 Michalopoulou M, Kambas A, Leontsini D, et al. Physical activity is associated with bone geometry of premenarcheal girls in a dose-dependent manner. Metabolism 2013;62:1811–18. 116 Maimoun L, Coste O, Philibert P, et al. Peripubertal female athletes in high-impact sports show improved bone mass acquisition and bone geometry. Metabolism 2013;62:1088–98. 117 Kitchin B. Nutrition counseling for patients with osteoporosis: a personal approach. J Clin Densitom 2013;16:426–31. 118 Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30. 119 Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010;95:4823–43. 120 Lovell G. Vitamin D status of females in an elite gymnastics program. Clin J Sport Med 2008;18:159–61. 121 Constantini NW, Arieli R, Chodick G, et al. High prevalence of vitamin D insufficiency in athletes and dancers. Clin J Sport Med 2010;20:368–71. 122 Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2013;383:146–55. 123 Misra M, Klibanski A. Bone health in anorexia nervosa. Curr Opin Endocrinol Diabetes Obes 2011;18:376–82. 124 Cobb KL, Bachrach LK, Sowers M, et al. The effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Exerc 2007;39:1464–73. 125 Warren MP, Miller KK, Olson WH, et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study. Contraception 2005;72:206–11. 126 Scheid JL, Toombs RJ, Ducher G, et al. Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women. Bone 2011;49:194–201. 127 Marini JC. Do bisphosphonates make children’s bones better or brittle? N Engl J Med 2003;349:423–6. 128 Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N Engl J Med 2007;356:1075–6. 129 Canalis E. Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 2010;95:1496–504. 130 Eriksen EF, Halse J, Moen MH. New developments in the treatment of osteoporosis. Acta Obstet Gynecol Scand 2013;92:620–36. 131 Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002;87:2883–91. 132 Misra M, McGrane J, Miller KK, et al. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 2009;45:493–8. 133 Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004;351:987–97. 134 Sienkiewicz E, Magkos F, Aronis KN, et al. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 2011;60:1211–21. 135 Chou SH, Chamberland JP, Liu X, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci USA 2011;108:6585– 90. 136 Sim I, Ebeling PR. Treatment of osteoporosis in men with bisphosphonates rationale and latest evidence. Ther Adv Musculoskelet Dis 2013;5:259–67. 137 Ebeling PR. Osteoporosis in men. Curr Opin Rheumatol 2013;25:542–52. 138 Thompson RA, Sherman RT. Eating disorders in sport. New York: Routledge, 2010. 139 Mitchell JE, Roerig J, Steffen K. Biological therapies for eating disorders. Int J Eat Disord 2013;46:470–7. 140 Skårderud F, Fladvad T, Garthe I, et al. Den dårlig ernærte utøveren. Vektreduksjon, kroppsmodifikasjon og spiseforstyrrelser i toppidrett. Retningslinjer for holdning og handling. Oslo: Olympiatoppen, 2012. http://www.olympiatoppen. no/fagomraader/idrettsernaering/Fagstoff/ page6827.html (accessed 4 June 2012). nummer 4 | september 2014 | Sport & Geneeskunde 27 Pagina 26
Pagina 28Scoor meer met een e-commerce shop in uw vakbladen. Velen gingen u voor en publiceerden nieuwsbrieven online.
Sport & Geneeskunde nummer 4 | november 2014 Lees publicatie 43Home